Joseph P Miletich - Net Worth and Insider Trading

Joseph P Miletich Net Worth

The estimated net worth of Joseph P Miletich is at least $7 Million dollars as of 2024-05-05. Joseph P Miletich is the Sr VP Rsch & Preclinical Dev of Amgen Inc and owns about 22,500 shares of Amgen Inc (AMGN) stock worth over $7 Million. Details can be seen in Joseph P Miletich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph P Miletich has not made any transactions after 2004-11-12 and currently still holds the listed stock(s).

Transaction Summary of Joseph P Miletich

Joseph P Miletich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph P Miletich owns 1 companies in total, including Amgen Inc (AMGN) .

Click here to see the complete history of Joseph P Miletich’s form 4 insider trades.

Insider Ownership Summary of Joseph P Miletich

Ticker	Comapny	Transaction Date	Type of Owner
AMGN	Amgen Inc	2004-11-12	Sr VP Rsch & Preclinical Dev

Joseph P Miletich Latest Holdings Summary

Joseph P Miletich currently owns a total of 1 stock. Joseph P Miletich owns 22,500 shares of Amgen Inc (AMGN) as of November 12, 2004, with a value of $7 Million.

Latest Holdings of Joseph P Miletich

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AMGN	Amgen Inc	2004-11-12	22,500	311.29	7,004,025

Holding Weightings of Joseph P Miletich

Joseph P Miletich Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph P Miletich has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 3,213 shares on November 12, 2004, which brought Joseph P Miletich around $192,812.

Insider Trading History of Joseph P Miletich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph P Miletich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph P Miletich Ownership Network

Ownership Network List of Joseph P Miletich

No Data

Ownership Network Relation of Joseph P Miletich

Joseph P Miletich Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

Joseph P Miletich is the Sr VP Rsch & Preclinical Dev of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Joseph P Miletich made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 4,758 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .

In summary, during the past 3 months, insiders sold 2,117 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 2,117 shares. During the past 18 months, 24,703 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,703 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amgen Inc Insider Transactions

No Available Data

Joseph P Miletich Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph P Miletich. Currently GuruFocus does not have mailing address information for Joseph P Miletich.

Discussions on Joseph P Miletich

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.